Posts from this topic will be added to your daily email digest and your homepage feed. Old data centers physically cannot support rows and rows of GPUs, which is one reason for the massive AI data ...
Nearly every SaaS product is either integrating AI or planning to do so. However, the term “AI” has become so broad that it’s ...
Laura Garber The year 2025 brought news of devastating fires, and troubling incidents involving minors on e-bikes. But the ...
iPhone's "System Data" can take up a lot of space on your smartphone. Here's what we know. Credit: Future Publishing via Getty Images It's a dreaded notification that some iPhone users have come to ...
Why one must take care when coding with generative AI. The challenges of vibe coding. How to get tips on Javascript coding.
The items were taken in the late 19th century from what was then called the Dutch East Indies. Indonesia had been trying to get them back for decades. By Nina Siegal Reporting from Amsterdam The ...
Three Democrats are seeking information from tech firms about the growing energy use of data centers and the utility bills of individuals and other businesses. By Ivan Penn and Karen Weise Three ...
This coal plant in central Pennsylvania, once the largest in the state, was shuttered in 2023 after powering the region for over 50 years. Earlier this year, wrecking crews blasted the plant’s cooling ...
The Southfield City Council approved a plan for a $1.5 billion data center in a 5-2 vote. Residents expressed concerns about the facility's high electricity usage, potential pollution and noise. The ...
In the golden hills of Puglia, a southern region of Italy known today for its olive trees, white cliffs and turquoise mediterranean coves, Lorenzo Avello has artificial intelligence on his mind.
Michigan may remember 2025 as the year of the data center. Developers have eyed at least 16 sites in 10 counties across the Lower Peninsula for the power-hungry server warehouses supporting artificial ...
Structure Therapeutics (GPCR) just moved its obesity pipeline up a gear by kicking off a first in human Phase 1 trial for ACCG-2671, its oral amylin receptor agonist targeting metabolic disease. See ...